CSIR- National Chemical Laboratory developed NP swabs for Covid19 sample collection. It is an appropriately small size for paediatric, nasopharyngeal or urethral genital sample collection. Approved by ICMR, the technology has been licensed to Ms. Chembond Polymers and Materials Pvt. Ltd. (CPML), Mumbai. CPML has now started commercial manufacturing of these nasal swabs under the name, Kemylon Swabs. The company has established a facility to produce 1 lakh swabs per day.
Recent Posts
SIDBI launches SAFE (SIDBI Assistance to Facilitate Emergency response against Coronavirus) scheme
Responsive to the need of the hour to fight Coronavirus from all fronts, Small Industries Development Bank of India (SIDBI), the principal financial institution...
Essity integrates BSN medical India into Essity organisation
Essity announced the final step in integrating BSN medical India into the Essity organisation.
Empirical Spine receives FDA Breakthrough Device Designation for its LimiFlex Device
Empirical Spine Inc., a company developing advanced solutions for the surgical treatment of spinal disorders, FDA has granted Breakthrough Device Designation (BDD) for its...
SANITIZATION EQUIPMENT DEVICES MARKET to Reach US$ 28.4 Billion By 2027
Global Sanitization Equipment Devices market is expected to grow at a CAGR of around 20.3% from 2020 to 2027 and reach the market value...
Removal of Large Blood Clots in Deep Vein Thrombosis
Control Medical Technology announced the FDA cleared Control 11F Mechanical Thrombectomy system was used to remove large blood clots from patients with deep vein...